International Patent: SYSTEMS AND METHODS TO DETECT INTERLEUKIN-17 OR COLONY-STIMULATING FACTOR-1 CHRONIC GRAFT VERSUS HOST DISEASE FROM THE PERIPHERAL BLOOD OF HEMATOPOIETIC TRANSPLANT RECIPIENTS

GENEVA, July 31 -- FRED HUTCHINSON CANCER CENTER filed a patent application (US2026/012033) for “SYSTEMS AND METHODS TO DETECT INTERLEUKIN-17 OR COLONY-STIMULATING FACTOR-1 CHRONIC GRAFT VERSUS HOST DISEASE FROM THE PERIPHERAL BLOOD OF HEMATOPOIETIC TRANSPLANT RECIPIENTS”. With publication no. WO/2026/161478, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12Q 1/686

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....